return_healthy_logo_480.png
Unlocking the Secrets to a Sharper Mind and Healthier Cells
17 avr. 2024 09h00 HE | Return Healthy
St. George, Utah, April 17, 2024 (GLOBE NEWSWIRE) -- In an era of rising health concerns, particularly those affecting cognitive functions, Return Healthy reveals its groundbreaking Cell...
Bloomage Showcases Bioactive Substance Innovations and Sustainability Commitment at China International Consumer Products Expo
Bloomage Showcases Bioactive Substance Innovations and Sustainability Commitment at China International Consumer Products Expo
15 avr. 2024 09h00 HE | Bloomage Biotech
Parsippany, New Jersey, USA, April 15, 2024 (GLOBE NEWSWIRE) -- Bloomage, a global company specializing in hyaluronic acid and other bioactive substance innovations, has attended the China...
22157.jpg
Global Anti-obesity Medication Market Trends Analysis Report 2024-2030: Social Media Influences and Strategic Partnerships, Mergers, Acquisitions, and Collaborations Shaping the Landscape
11 avr. 2024 11h14 HE | Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market Size, Share & Trends Analysis Report" report has been added to ResearchAndMarkets.com's offering.The global...
FirstClass Healthcare.png
FirstClass Healthcare Earns Perfect Score on NCCHC (National Commission on Correctional Health Care) Accreditation in the Gwinnett County Jail
10 avr. 2024 11h37 HE | FirstClass Healthcare
FirstClass Healthcare Earns Perfect Score on National Commission on Correctional Health Care Accreditation in the Gwinnett County Jail in Georgia.
UMeWorld to Debut the World's First & Only Weight Loss Cooking Oil in the US
09 avr. 2024 08h00 HE | UMeWorld Limited
MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is excited to announce that the company has secured an exclusive license to use proprietary enzymatic technologies to...
Reuters Publishes Pulsar Helium Film Documentary
05 avr. 2024 07h38 HE | Pulsar Helium
Reuters Publishes Pulsar Helium Film Documentary
Fractyl-Logo.png
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
02 avr. 2024 08h00 HE | Fractyl Health, Inc.
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation
Fractyl-Logo.png
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
01 avr. 2024 07h00 HE | Fractyl Health, Inc.
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Fractyl-Logo.png
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
01 avr. 2024 06h00 HE | Fractyl Health, Inc.
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs